Tranche Update on Henan Lingrui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 2, 2021.

From February 1, 2021 to March 31, 2021, the company has repurchased 2,899,300 shares, representing 0.51% for CNY 25.22 million. With this, the company has completed the repurchase of 2,899,300 shares, representing 0.51% for CNY 25.22 million under the buyback announced on February 2, 2021.